Related Experiment Video
Updated: Jan 10, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Life Course Approach to Familial Hypercholesterolemia
Marcio H Miname1, Fernanda Del Castanhel1, Marjorie H Mizuta1
1Lipid Clinic Heart Institute (InCor) University of São Paulo Medical School Hospital, São Paulo, Brazil.
Familial hypercholesterolemia (FH) advances include better understanding of its natural history, risk, and treatment. Early diagnosis and childhood intervention are crucial for preventing premature cardiovascular disease.
Area of Science:
- Cardiology
- Genetics
- Pharmacology
Background:
- Familial hypercholesterolemia (FH) affects ~1 in 310 individuals globally.
- FH significantly increases the risk of premature atherosclerotic cardiovascular disease (ASCVD).
Purpose of the Study:
- To review recent advancements in the understanding and management of Familial hypercholesterolemia (FH).
Main Methods:
- Review of current literature on FH natural history, risk stratification, and therapeutic strategies.
- Analysis of diagnostic criteria including clinical presentation and genetic testing.
- Evaluation of risk assessment tools like coronary artery calcium scoring.
- Assessment of pharmacological interventions including statins, ezetimibe, and PCSK9 inhibitors.
Main Results:
- Significant progress in understanding FH natural history, risk stratification, and treatment efficacy.
- Early diagnosis via clinical or genetic testing is vital for timely intervention.
- Cumulative LDL-cholesterol exposure correlates with ASCVD onset and progression.
- Novel risk prediction models and imaging techniques (coronary artery calcium scoring) improve risk stratification.
- Effective pharmacological treatments include statins, ezetimibe, and PCSK9 inhibitors.
- Geriatric FH management requires consideration of frailty and comorbidities.
Conclusions:
- Advances in FH knowledge necessitate early diagnosis and prompt, lifelong treatment.
- Personalized therapeutic approaches, considering age and comorbidities, are essential for optimal outcomes in FH patients.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis III: Management
Lipid Catabolism
Lipids: Dietary Sources and Requirements
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

